Skip to content

13F-HR filed by MPM BIOIMPACT LLC

MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 33 holding rows worth $385,456,912.

Accession
0000950123-23-002440
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 33 entries on the cover page, a total value of $385,456,912 stated on the cover page (in dollars after the unit check, H1), rows summing to $385,456,912 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CULLINAN THERAPEUTICS INC230031106COM7,648,268$80,689,227dollars as filed
ITEOS THERAPEUTICS INC46565G104COM1,745,943$34,098,267dollars as filed
INHIBRX INC45720L107COM1,286,435$31,697,758dollars as filed
REPARE THERAPEUTICS INC760273102COM1,639,849$24,122,179dollars as filed
IVERIC BIO INC46583P102COM1,059,688$22,687,920dollars as filed
UNIQURE NVN90064101SHS939,966$21,309,029dollars as filed
GERON CORP374163103COM8,466,981$20,490,094dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM455,238$15,883,254dollars as filed
VERVE THERAPEUTICS INC92539P101COM808,661$15,647,590dollars as filed
REGENXBIO INC75901B107COM621,372$14,092,717dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM2,149,550$13,735,625dollars as filed
PROVENTION BIO INC74374N102COM898,483$9,496,965dollars as filed
INSMED INC COM PAR $.01457669307Stock410,463$8,201,051dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock26,773$7,770,863dollars as filed
HARMONY BIOSCIENCES HLDGS IN413197104COM139,377$7,679,673dollars as filed
REATA PHARMACEUTICALS INC75615P103CL A194,181$7,376,936dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock371,639$6,800,994dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM281,711$5,924,382dollars as filed
WEREWOLF THERAPEUTICS INC95075A107CMN2,388,011$4,895,423dollars as filed
AMICUS THERAPEUTICS INC03152W109COM400,410$4,889,006dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock51,975$4,008,832dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM262,069$3,878,621dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock149,043$3,550,204dollars as filed
G1 THERAPEUTICS INC3621LQ109COM650,000$3,529,500dollars as filed
TCR2 THERAPEUTICS INC87808K106COM3,370,982$3,367,611dollars as filed
HARPOON THERAPEUTICS INC41358P106COM3,196,707$2,320,809dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK195,942$2,198,469dollars as filed
CHINOOK THERAPEUTICS INC16961L106COM80,000$2,096,000dollars as filed
PRAXIS PRECISION MEDICINES I74006W108COM610,000$1,451,800dollars as filed
ONCORUS INC68236R103COM2,377,031$601,389dollars as filed
TECTONIC THERAPEUTIC INC COM05455M100Stock647,918$461,901dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM144,888$260,798dollars as filed
INOZYME PHARMA INC45790W108COM230,500$242,025dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-002440this filing2023-02-14acceptance time not in the bulk data set